Menu
Back to Journals » Drug Design, Development and Therapy » Volume 8
Original Research
Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,317 | Dovepress* | 14,272+ | 1,754 | 16,026 | |
| PubMed Central* | 1,045 | 465 | 1,510 | ||
| Totals | 15,317 | 2,219 | 17,536 | ||
|
*Since 25 August 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar